Health ❯ Reproductive Health ❯ Medication Abortion

Mifepristone

Misoprostol Patient Access FDA Regulations FDA Approval Telehealth Access Availability Telemedicine Health Care Access Access Issues Health Regulations Safety and Effectiveness Threat to Availability Telehealth Services Pregnancy Termination Safety and Efficacy Access to Abortion FDA Decisions FDA Approval Process Drug Safety Emergency Room Visits Abortion Statistics FDA Regulation Access to Reproductive Health Care Abortion Pills Patient Safety Complications and Risks

Supreme Court Temporarily Restores Mail and Telehealth Access to Mifepristone

The stay keeps the FDA’s 2023 telehealth policy in place during emergency briefing.

Judge Pauses Louisiana Challenge, Leaves Mail-Order Abortion Pill Policy Intact

ACLU Sues FDA to Obtain Records on Mifepristone Review

Senate Democrats Press FDA on Mifepristone Review After Court Strikes Down Restrictions

Missouri AG Files Suit Over Planned Parenthood’s Mifepristone Safety Claims

Fourth Circuit Affirms West Virginia’s Restriction on Abortion Pill Mifepristone